The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma.
 
Ravindra Uppaluri
Consulting or Advisory Role - Merck
Research Funding - Merck
 
Nancy Y. Lee
Stock and Other Ownership Interests - AstraZeneca (I); AstraZeneca (I)
Consulting or Advisory Role - Merck; Merck Serono; pfizer; Sanofi
Research Funding - AstraZeneca
 
William Westra
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Merck
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Human Longevity, Inc; Incyte; Mavu Pharmaceutical; Merck; Nanobiotix; Pfizer
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Immunomic Therapeutics; Loxo; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst); VentiRx (Inst)
 
Stephane Temam
No Relationships to Disclose
 
Christophe Le Tourneau
Honoraria - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; Nanobiotix; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; Nanobiotix; Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome
 
Rebecca Chernock
Consulting or Advisory Role - Merck; Roche
Travel, Accommodations, Expenses - Roche
 
Sufia Safina
No Relationships to Disclose
 
Arkadiy Klochikhin
No Relationships to Disclose
 
Amichay Meirovitz
Consulting or Advisory Role - AstraZeneca; Merck; Merck Serono
 
Irene Braña
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - AstraZeneca Spain; Bristol-Myers Squibb; Merck Serono
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gliknik; Janssen; Kura Oncology; Merck Sharp & Dome; Novartis; Orion; Pfizer
Travel, Accommodations, Expenses - AstraZeneca Spain; Merck Serono
 
Joy Yang Ge
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Ramona F. Swaby
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Behzad Bidadi
No Relationships to Disclose
 
Douglas Adkins
Consulting or Advisory Role - Celgene; Celgene (Inst); Lilly; Lilly (Inst); Merck; Merck (Inst); Pfizer; Pfizer (Inst)
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Atara Biotherapeutics (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cellceutix (Inst); Celldex (Inst); Enzychem Lifesciences (Inst); Exelixis (Inst); Gliknik (Inst); Innate Pharma (Inst); Kura Oncology (I); Lilly (Inst); Matrix Biomed (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer